跳至主要内容
临床试验/NL-OMON35335
NL-OMON35335已完成2 期

Improving practicality of radiofrequency ablation for eradication of Barrett*s mucosa: a randomized trial comparing two different treatment regimens for focal ablation using the HALO90 System - Optimization of HALO90 ablation of Barrett's mucosa

Academisch Medisch Centrum0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Scheduled HALO90 ablation for BE (with or without neoplasia) after prior circumferential ablation using the HALO360 System for BE with flat low-grade dysplasia (LGD) or high-grade dysplasia (HGD) or for BE (with or without neoplasia) after prior endoscopic resection (ER) for lesions containing HGD or and early cancer.
  • - One or more BE islands with a minimum size of 5-mm.
  • - Written informed consent

排除标准

  • Patients with endoscopically active inflammation in the treatment zone.
  • - Esophageal stenosis preventing advancement of the endoscope with the HALO90 catheter.
  • - Patients unable to give informed consent.

研究者

相似试验